D

Daan Gene Co Ltd
SZSE:002030

Watchlist Manager
Daan Gene Co Ltd
SZSE:002030
Watchlist
Price: 6.41 CNY 0.79%
Market Cap: 9B CNY

Wall Street
Price Targets

Price Targets Summary
Daan Gene Co Ltd

There are no price targets for Daan Gene Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Daan Gene Co Ltd Competitors:
Price Targets
688177
Bio-Thera Solutions Ltd
45% Upside
ORGO
Organogenesis Holdings Inc
106% Upside
603087
Gan & Lee Pharmaceuticals
8% Downside
KURN
Kuros Biosciences AG
32% Upside
ORKA
Oruka Therapeutics Inc
80% Upside
BMEA
Biomea Fusion Inc
403% Upside
HPHA
Heidelberg Pharma AG
75% Upside
DVAX
Dynavax Technologies Corp
37% Upside

Revenue
Forecast

Revenue Estimate
Daan Gene Co Ltd

For the last 13 years the compound annual growth rate for Daan Gene Co Ltd's revenue is 5%. The projected CAGR for the next 8 years is 11%.

5%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Daan Gene Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Net Income
Forecast

Net Income Estimate
Daan Gene Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Daan Gene Co Ltd's stock price target?
Not Available

Daan Gene Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Daan Gene Co Ltd's Revenue forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Daan Gene Co Ltd's revenue is 5%. The projected CAGR for the next 8 years is 11%.

Back to Top